XML 15 R4.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated Statements of Income and Comprehensive Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 25, 2016
Sep. 27, 2015
Sep. 25, 2016
Sep. 27, 2015
Revenues $ 19,631 $ 19,044 $ 60,835 $ 57,176
Cost of products sold 13,634 13,144 42,533 39,410
Gross profit 5,997 5,900 18,302 17,766
Operating expenses:        
Research and development 1,357 1,224 4,438 3,917
Selling, general and administrative 3,502 3,503 11,745 11,037
Total operating expenses 4,859 4,727 16,183 14,954
Operating income 1,138 1,173 2,119 2,812
Other (expense) income:        
Interest and financing expense (50) (65) (213) (195)
Miscellaneous 20 70 46 39
Income before income tax provision 1,108 1,178 1,952 2,656
Income tax provision 92 130 213 312
Net income 1,016 1,048 1,739 2,344
Net loss (income) attributable to non-controlling interest 3 (1) 25 23
Net income attributable to Ultralife Corporation 1,019 1,047 1,764 2,367
Other comprehensive loss:        
Foreign currency translation adjustment (613) (349) (1,314) (283)
Comprehensive income attributable to Ultralife Corporation $ 406 $ 698 $ 450 $ 2,084
Net income per share attributable to Ultralife common shareholders – basic (in dollars per share) $ 0.07 $ 0.07 $ 0.12 $ 0.14
Net income per share attributable to Ultralife common shareholders – diluted (in dollars per share) $ 0.07 $ 0.07 $ 0.11 $ 0.14
Weighted average shares outstanding – basic (in shares) 15,207 15,633 15,262 16,503
Potential common shares (in shares) 91 107 184 47
Weighted average shares outstanding - diluted (in shares) 15,298 15,740 15,446 16,550